133 related articles for article (PubMed ID: 12790321)
1. Molecular mechanisms of carcinogenesis in gastric cancer.
Höfler H; Becker KF
Recent Results Cancer Res; 2003; 162():65-72. PubMed ID: 12790321
[TBL] [Abstract][Full Text] [Related]
2. The use of molecular biology in diagnosis and prognosis of gastric cancer.
Becker KF; Keller G; Hoefler H
Surg Oncol; 2000 Jul; 9(1):5-11. PubMed ID: 11525306
[TBL] [Abstract][Full Text] [Related]
3. Gastric adenocarcinoma: pathomorphology and molecular pathology.
Werner M; Becker KF; Keller G; Höfler H
J Cancer Res Clin Oncol; 2001 Apr; 127(4):207-16. PubMed ID: 11315254
[TBL] [Abstract][Full Text] [Related]
4. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms involved in the pathogenesis of gastric carcinoma: interactions between genetic alterations, cellular phenotype and cancer histotype.
Fiocca R; Luinetti O; Villani L; Mastracci L; Quilici P; Grillo F; Ranzani GN
Hepatogastroenterology; 2001; 48(42):1523-30. PubMed ID: 11813565
[TBL] [Abstract][Full Text] [Related]
6. Expression of cadherin-catenin cell adhesion molecules, phosphorylated tyrosine residues and growth factor receptor-tyrosine kinases in gastric cancers.
Akimoto S; Ochiai A; Inomata M; Hirohashi S
Jpn J Cancer Res; 1998 Aug; 89(8):829-36. PubMed ID: 9765619
[TBL] [Abstract][Full Text] [Related]
7. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma.
Yonemura Y; Nojima N; Kaji M; Fujimura T; Itoh H; Ninomiya I; Miyazaki I; Endo Y; Sasaki T
Cancer; 1995 Sep; 76(6):941-53. PubMed ID: 8625219
[TBL] [Abstract][Full Text] [Related]
9. [Multistep stomach carcinogenesis].
Yokozaki H; Tahara E
Nihon Rinsho; 1996 Apr; 54(4):1066-71. PubMed ID: 8920675
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system.
Heiss MM; Babic R; Allgayer H; Gruetzner KU; Jauch KW; Loehrs U; Schildberg FW
J Clin Oncol; 1995 Aug; 13(8):2084-93. PubMed ID: 7636552
[TBL] [Abstract][Full Text] [Related]
11. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer.
Gamboa-Dominguez A; Seidl S; Reyes-Gutierrez E; Hermannstädter C; Quintanilla-Martinez L; Busch R; Höfler H; Fend F; Luber B
J Clin Pathol; 2007 Jul; 60(7):756-61. PubMed ID: 17483253
[TBL] [Abstract][Full Text] [Related]
13. Molecular biology of gastric cancer.
Tahara E
World J Surg; 1995; 19(4):484-8; discussion 489-90. PubMed ID: 7676688
[TBL] [Abstract][Full Text] [Related]
14. Disordered beta-catenin expression and E-cadherin/CDH1 promoter methylation in gastric carcinoma.
Wang L; Zhang F; Wu PP; Jiang XC; Zheng L; Yu YY
World J Gastroenterol; 2006 Jul; 12(26):4228-31. PubMed ID: 16830381
[TBL] [Abstract][Full Text] [Related]
15. Molecular biological observations in gastric cancer.
Tahara E; Semba S; Tahara H
Semin Oncol; 1996 Jun; 23(3):307-15. PubMed ID: 8658214
[TBL] [Abstract][Full Text] [Related]
16. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival.
Zhou YN; Xu CP; Han B; Li M; Qiao L; Fang DC; Yang JM
World J Gastroenterol; 2002 Dec; 8(6):987-93. PubMed ID: 12439911
[TBL] [Abstract][Full Text] [Related]
17. Relation between cell-to-cell adhesion and angiogenesis and clinico-morphological prognostic factors in patients with gastric cancer.
Bazas VM; Lukyanova NY; Demash DV; Galakhin KO; Myasoedov DV
Exp Oncol; 2008 Sep; 30(3):235-9. PubMed ID: 18806748
[TBL] [Abstract][Full Text] [Related]
18. The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis.
Brungs D; Chen J; Aghmesheh M; Vine KL; Becker TM; Carolan MG; Ranson M
Oncotarget; 2017 Apr; 8(14):23099-23109. PubMed ID: 28416743
[TBL] [Abstract][Full Text] [Related]
19. Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer.
Kaneko T; Konno H; Baba M; Tanaka T; Nakamura S
Cancer Sci; 2003 Jan; 94(1):43-9. PubMed ID: 12708473
[TBL] [Abstract][Full Text] [Related]
20. [Dysfunction of cadherin cell adhesion system in cancer invasion and metastasis].
Ochiai A
Gan To Kagaku Ryoho; 1999 Mar; 26(4):565-71. PubMed ID: 10097760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
